| Relationship between neutrophil-lymphocyte ratio and insulin resistance in newly diagnosed type 2 diabetes mellitus patients M Lou, P Luo, R Tang, Y Peng, S Yu, W Huang, L He BMC endocrine disorders 15, 1-6, 2015 | 231 | 2015 |
| Crosstalk between the MSI status and tumor microenvironment in colorectal cancer A Lin, J Zhang, P Luo Frontiers in immunology 11, 552467, 2020 | 213 | 2020 |
| Role of the dynamic tumor microenvironment in controversies regarding immune checkpoint inhibitors for the treatment of non-small cell lung cancer (NSCLC) with EGFR mutations A Lin, T Wei, H Meng, P Luo, J Zhang Molecular cancer 18, 1-18, 2019 | 167 | 2019 |
| Immune checkpoint modulators in cancer immunotherapy: recent advances and emerging concepts Y Wang, H Zhang, C Liu, Z Wang, W Wu, N Zhang, L Zhang, J Hu, P Luo, ... Journal of Hematology & Oncology 15 (1), 111, 2022 | 121 | 2022 |
| The relationship between neutrophil-to-lymphocyte ratio and diabetic peripheral neuropathy in Type 2 diabetes mellitus T Xu, Z Weng, C Pei, S Yu, Y Chen, W Guo, X Wang, P Luo, J Sun Medicine 96 (45), e8289, 2017 | 86 | 2017 |
| Immunosenescence: molecular mechanisms and diseases Z Liu, Q Liang, Y Ren, C Guo, X Ge, L Wang, Q Cheng, P Luo, Y Zhang, ... Signal transduction and targeted therapy 8 (1), 200, 2023 | 73 | 2023 |
| ZFHX3 mutation as a protective biomarker for immune checkpoint blockade in non-small cell lung cancer J Zhang, N Zhou, A Lin, P Luo, X Chen, H Deng, S Kang, L Guo, W Zhu, ... Cancer Immunology, Immunotherapy 70, 137-151, 2021 | 67 | 2021 |
| CAMOIP: a web server for comprehensive analysis on multi-omics of immunotherapy in pan-cancer A Lin, C Qi, T Wei, M Li, Q Cheng, Z Liu, P Luo, J Zhang Briefings in bioinformatics 23 (3), bbac129, 2022 | 65 | 2022 |
| Machine learning-based identification of tumor-infiltrating immune cell-associated lncRNAs for improving outcomes and immunotherapy responses in patients with low-grade glioma N Zhang, H Zhang, W Wu, R Zhou, S Li, Z Wang, Z Dai, L Zhang, F Liu, ... Theranostics 12 (13), 5931, 2022 | 63 | 2022 |
| Efficacy and safety of osimertinib in treating EGFR‐mutated advanced NSCLC: A meta‐analysis L Yi, J Fan, R Qian, P Luo, J Zhang International journal of cancer 145 (1), 284-294, 2019 | 62 | 2019 |
| Machine learning-based tumor-infiltrating immune cell-associated lncRNAs for predicting prognosis and immunotherapy response in patients with glioblastoma H Zhang, N Zhang, W Wu, R Zhou, S Li, Z Wang, Z Dai, L Zhang, Z Liu, ... Briefings in bioinformatics 23 (6), bbac386, 2022 | 54 | 2022 |
| A novel mutation panel for predicting etoposide resistance in small-cell lung cancer Z Qiu, A Lin, K Li, W Lin, Q Wang, T Wei, W Zhu, P Luo, J Zhang Drug Design, Development and Therapy, 2021-2041, 2019 | 52 | 2019 |
| Single-cell RNA sequencing reveals the heterogeneity of tumor-associated macrophage in non-small cell lung cancer and differences between sexes Q Yang, H Zhang, T Wei, A Lin, Y Sun, P Luo, J Zhang Frontiers in Immunology 12, 756722, 2021 | 50 | 2021 |
| The efficacy and safety of ALK inhibitors in the treatment of ALK‐positive non‐small cell lung cancer: A network meta‐analysis J Fan, T Fong, Z Xia, J Zhang, P Luo Cancer medicine 7 (10), 4993-5005, 2018 | 41 | 2018 |
| Glia maturation factor-β: A potential therapeutic target in neurodegeneration and neuroinflammation J Fan, T Fong, X Chen, C Chen, P Luo, H Xie Neuropsychiatric disease and treatment, 495-504, 2018 | 40 | 2018 |
| Age, sex, and specific gene mutations affect the effects of immune checkpoint inhibitors in colorectal cancer A Lin, H Zhang, X Hu, X Chen, G Wu, P Luo, J Zhang Pharmacological Research 159, 105028, 2020 | 38 | 2020 |
| ATM mutations benefit bladder cancer patients treated with immune checkpoint inhibitors by acting on the tumor immune microenvironment R Yi, A Lin, M Cao, A Xu, P Luo, J Zhang Frontiers in Genetics 11, 933, 2020 | 34 | 2020 |
| CDYL promotes the chemoresistance of small cell lung cancer by regulating H3K27 trimethylation at the CDKN1C promoter Z Qiu, W Zhu, H Meng, L Tong, X Li, P Luo, L Yi, X Zhang, L Guo, T Wei, ... Theranostics 9 (16), 4717, 2019 | 34 | 2019 |
| Age and mutations as predictors of the response to immunotherapy in head and neck squamous cell cancer Y Zhang, A Lin, Y Li, W Ding, H Meng, P Luo, J Zhang Frontiers in cell and developmental biology 8, 608969, 2020 | 33 | 2020 |
| Intranasal administration of a single dose of a candidate live attenuated vaccine derived from an NSP16-deficient SARS-CoV-2 strain confers sterilizing immunity in animals ZW Ye, CP Ong, K Tang, Y Fan, C Luo, R Zhou, P Luo, Y Cheng, VS Gray, ... Cellular & molecular immunology 19 (5), 588-601, 2022 | 30 | 2022 |
Zhang Jianzhujiang hospital of southern medical university在 i.smu.edu.cn 的电子邮件经过验证
